2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumor action

US8492570B2 · kind B2 · utility

Assignee

• Sterix Limited · GB

Inventors

• Alexander Hillisch · Solingen, DE
• Olaf Peters · Bad Tabarz, DE
• Christian Gege · Ehingen (Donau), DE
• Wilko Regenhardt · Munich, DE
• Dirk Kosemund · Berlin, DE
• Gerhard Siemeister · Berlin, DE
• Eberhard Unger · Cospeda, DE
• Ulrich Bothe · Berlin, DE

Key dates

• Filing date: Sep 22, 2008
• Grant date: Jul 23, 2013
• Expiry date: Jan 31, 2029

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07J41/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to the use of 2-substituted estra-1,3,5(10)-triene-3-yl sulfamates of general formula I, in addition to their pharmaceutically acceptable salts for producing a medicament. Said compounds have an anti-tumour action.